Skip to main content
. 2023 Oct 17;31(2):e16106. doi: 10.1111/ene.16106

FIGURE 3.

FIGURE 3

Relation predictive values (including monthly migraine days [MMD] reduction) and the reduction in depressive symptoms. Reduction in HADS‐D is positively associated with MMD reduction, but treatment with anti‐CGRP medication had an additional effect on the reduction in HADS‐D (β = 1.65, p = 0.01) compared to control.